|
AMGN's Free Cash Flow Growth by Quarter and Year
Amgen Inc 's Free Cash Flow results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
Free Cash Flow Growth Y/Y▼
|
Free Cash Flow Growth Y/Y▼
|
AMGN Free Cash Flow (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
538.00
|
2,649.00
|
2,808.00
|
2,153.00
|
III Quarter |
September |
2,760.00
|
2,978.00
|
2,418.00
|
3,368.00
|
II Quarter |
June |
4,109.00
|
1,930.00
|
1,931.00
|
2,842.00
|
I Quarter |
March |
1,064.00
|
2,164.00
|
2,104.00
|
2,134.00
|
FY |
|
8,471.00
|
9,721.00
|
9,261.00
|
10,497.00
|
AMGN Free Cash Flow fourth quarter 2023 Y/Y Growth Comment |
Amgen Inc reported drop in Free Cash Flow in the fourth quarter 2023 by -79.69% to $ 538.00 millions, from the same quarter in 2022. The fall in the fourth quarter 2023 Amgen Inc 's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow increase of 10.99%.
Looking into fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Free Cash Flow growth. While Amgen Inc ' s Free Cash Flow meltdown of -79.69% ranks overall at the positon no. 965 in the fourth quarter 2023.
|
AMGN Free Cash Flow ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-79.69 % |
-5.66 % |
30.42 % |
-14.36 % |
III Quarter |
September |
-7.32 % |
23.16 % |
-28.21 % |
-0.27 % |
II Quarter |
June |
112.9 % |
-0.05 % |
-32.05 % |
100.99 % |
I Quarter |
March |
-50.83 % |
2.85 % |
-1.41 % |
15.66 % |
FY |
|
-12.86 % |
4.97 % |
-11.77 % |
14.72 % |
AMGN Free Cash Flow (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-80.51 % |
-11.05 % |
16.13 % |
-36.07 % |
III Quarter |
September |
-32.83 % |
54.3 % |
25.22 % |
18.51 % |
II Quarter |
June |
286.18 % |
-10.81 % |
-8.22 % |
33.18 % |
I Quarter |
March |
-59.83 % |
-22.93 % |
-2.28 % |
-15.12 % |
FY (Year on Year) |
|
-12.86 % |
4.97 % |
-11.77 % |
14.72 % |
Free Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
145.53 % |
10.99 % |
-18.83 % |
(Dec. 31. 2005) |
|
(Dec 31 2019) |
|
Free Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
145.53 % |
10.99 % |
-18.83 % |
(Dec. 31. 2005) |
|
(Dec 31 2019) |
|
Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Amgen Inc 's Q/Q Free Cash Flow Growth
Free Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
5931.25 % |
93.03 % |
-100 % |
(June 30. 2004) |
|
|
AMGN's IV. Quarter Q/Q Free Cash Flow Comment |
In the IV. Quarter 2023 Amgen Inc reported fall in Free Cash Flow sequentially by -80.51% to $ 538.00 millions, from $ 2,760.00 millions achived a quarter before.
If you look into present shortcoming in the quarter, you should take into consideration, that commonly IV. Quarter performance occur weaker in contrast to the preciding period, Caroline De Smet, an industry researcher said.
Within Biotechnology & Pharmaceuticals industry 6 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1317. |
|
|
Free Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
5931.25 % |
93.03 % |
-100 % |
(June 30. 2004) |
|
|
AMGN's IV. Quarter Q/Q Free Cash Flow Comment |
In the IV. Quarter 2023 Amgen Inc disclosed fall in Free Cash Flow from the third quarter by -80.51% to $ 538.00 millions, from $ 2,760.00 millions released in the previous quarter.
If you analyse present shortcoming at the IV. Quarter, you suppose to presume, that usually IV. Quarter 2023 results emerge sluggish then in the third quarter, Caroline De Smet, an industry researcher mentioned.
Within Biotechnology & Pharmaceuticals industry 6 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1317. |
|
Amgen Inc 's 12 Months Free Cash Flow Growth Year on Year
Free Cash Flow TTM Growth |
12 Months Ending (Dec 31 2023) |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
Cumulative Free Cash Flow 12 Months Ending |
$ 9,583.00 |
$ 11,785.00 |
$ 11,915.00 |
$ 9,711.00 |
$ 10,657.00 |
Y / Y Free Cash Flow Growth (TTM) |
-10.08 % |
9.5 % |
15.85 % |
-5.03 % |
5.09 % |
Year on Year Free Cash Flow Growth Overall
Ranking |
# 878 |
# 1133 |
# 1100 |
# 810 |
# 1385 |
Seqeuential Free Cash Flow Change (TTM) |
-18.68 % |
-1.09 % |
22.7 % |
-8.88 % |
-0.98 % |
Seq. Free Cash Flow Growth (TTM) Overall
Ranking |
# 1183 |
# 1342 |
# 1359 |
# 695 |
# 848 |
Cumulative Free Cash Flow growth
Comment |
For the 12 months ended Dec 31 2023 Amgen Inc reported a decline in Free Cash Flow by -10.08% year on year, to $9,583 millions, compare to the 9.5% growth at Sep 30 2023.
In the Healthcare sector 72 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 878, from total ranking in previous quarter at 1133. |
Free Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
145.53 % |
10.99 % |
-18.83 % |
|
|
|
|
|
Free Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
145.53 % |
10.99 % |
-18.83 % |
|
|
|
Free Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 4 |
Sector |
# 86 |
S&P 500 |
# 1183 |
|
Cumulative Free Cash Flow growth
Comment |
For the 12 months ended Dec 31 2023 Amgen Inc reported a decline in Free Cash Flow by -10.08% year on year, to $9,583 millions, compare to the 9.5% growth at Sep 30 2023.
In the Healthcare sector 72 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 878, from total ranking in previous quarter at 1133. |
Free Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
145.53 % |
10.99 % |
-18.83 % |
|
|
|
Free Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
145.53 % |
10.99 % |
-18.83 % |
|
|
|
Free Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 4 |
Sector |
# 86 |
S&P 500 |
# 1183 |
|